Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany

Crystal Watson,1 Christine Prosser,2 Sebastian Braun,2 Pamela B Landsman-Blumberg,3 Erika Gleissner,4 Sarah Naoshy1 1Health Economics and Outcomes Research, Global Market Access, Biogen, Cambridge, MA, USA; 2Real World Evidence, Xcenda GmbH, Hanover, Germany; 3Applied Data Analytics, Xcenda LLC, Pal...

Full description

Bibliographic Details
Main Authors: Watson C, Prosser C, Braun S, Landsman-Blumberg PB, Gleissner E, Naoshy S
Format: Article
Language:English
Published: Dove Medical Press 2017-02-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
multiple sclerosis
relapsing-remitting
healthcare resource utilization
costs
outcomes
natalizumab
Online Access:https://www.dovepress.com/germany-health-care-resource-utilization-before-and-after-nataliz-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/germany-health-care-resource-utilization-before-and-after-nataliz-peer-reviewed-article-CEOR

Similar Items